Home
Search Center
Journal List
CMA
Contact US
|
Chinese
You Position:
Home
> Paper
Circadian rhythms of melatonin, cortisol, and clock gene expression in the hyperacute phase of wake-up stroke: study design and measurement
( views:0, downloads:0 )
Author:
No author available
Journal Title:
Chinese Medical Journal
Issue:
21
DOI:
10.1097/CM9.0000000000001111
Key Word:
No keyword available
Abstract: No abstract available
Reference
[1]Cheng-Yun Li,Wen-Wen Zhang,Ji-Lian Xiang,etc.
Identification of microRNAs as novel biomarkers for esophageal squamous cell carcinoma: a study based on The Cancer Genome Atlas (TCGA) and bioinformatics
[J].2019,(18).
[2]Roberto, Chalela,Víctor, Curull,César, Enríquez,etc.
Lung adenocarcinoma: from molecular basis to genome-guided therapy and immunotherapy.
[J].2017,9(7).
[3]Ryo Yamashita,Mitsuo Sato,Tomohiko Kakumu,etc.
Growth inhibitory effects of miR‐221 and miR‐222 in non‐small cell lung cancer cells
[J].2015,4(4).
[4]Wu Si-Ran,Wu Qiong,Shi Yong-Quan.
Recent advances of miRNAs in the development and clinical application of gastric cancer
[J].2020,133(15).
[5]Fritz, BR,Gentleman, R,Knudsen, BS,etc.
Circulating microRNAs as stable blood-based markers for cancer detection
[J].2008,105(30).
[6]Stefano, Sestini,Mattia, Boeri,Alfonso, Marchianò,etc.
[Lung cancer screening in high-risk subjects: early detection with LDCT and risk stratification using miRNA-based blood test].
[J].1900,40.
[7]Yi, Shen,Dongfang, Tang,Ruyong, Yao,etc.
microRNA expression profiles associated with survival, disease progression, and response to gefitinib in completely resected non-small-cell lung cancer with EGFR mutation.
[J].2013,30(4).
[8].
Selective release of microRNA species from normal and malignant mammary epithelial cells.
[J].2010.
[9]Toschi, Luca,Rossi, Sabrina,Finocchiaro, Giovanna,etc.
Non-small cell lung cancer treatment (r)evolution: ten years of advances and more to come.
[J].2017,11(770-791).
[10]Chitra, Rajagopal,K B, Harikumar.
The Origin and Functions of Exosomes in Cancer.
[J].2018,8(Spec ).
[11]Yunxia,Li,Xiaomei,Cui,Yongdeng,Li,etc.
Upregulated expression of miR-421 is associated with poor prognosis in non-small-cell lung cancer.
[J].2018,10.
[12]Jun Zhang,Jintao Bi,Jianning Song,etc.
Identification of suitable reference genes for qPCR analysis of serum microRNA in gastric cancer patients.
[J].2012,57(4).
[13]Gloria, Bertoli,Claudia, Cava,Isabella, Castiglioni.
MicroRNAs: New Biomarkers for Diagnosis, Prognosis, Therapy Prediction and Therapeutic Tools for Breast Cancer.
[J].2015,5.
[14]Calin GA,Croce CM.
MicroRNA signatures in human cancers.
[J].2006,6(11).
[15]Thorarinn Blondal,S\u00f8ren Jensby Nielsen,Adam Baker,etc.
Assessing sample and miRNA profile quality in serum and plasma or other biofluids
[J].2012,59(1).
[16].
Comprehensive molecular profiling of lung adenocarcinoma
[J].2014,511(7511).
[17].
Circulating exosomal microRNAs as prognostic biomarkers for non-small-cell lung cancer.
[J].2017,8(8).
[18]Wei, Sun,Xun, Yuan,Yijun, Tian,etc.
Non-invasive approaches to monitor EGFR-TKI treatment in non-small-cell lung cancer.
[J].2015,8.
[19]Chen, Jun,Fan, Yaguang,Li, Xin,etc.
Expression levels of microRNA-145 and microRNA-10b are associated with metastasis in non-small cell lung cancer
[J].2016,17(3).
[20]Shabnam, Abtahi,Mahyar, Malekzadeh,Ghafour, Nikravan,etc.
Measurement of Lung Cancer Tumor Markers in a Glass Wool Company Workers Exposed to Respirable Synthetic Vitreous Fiber and Dust.
[J].2018,9(1).
[21]Wang, Lu-Kai,Hsiao, Tzu-Hung,Hong, Tse-Ming,etc.
MicroRNA-133a Suppresses Multiple Oncogenic Membrane Receptors and Cell Invasion in Non-Small Cell Lung Carcinoma.
[J].2014,9(5).
[22]Hao, Chang,Yue-Hong, Liu,Li-Li, Wang,etc.
MiR-182 promotes cell proliferation by suppressing FBXW7 and FBXW11 in non-small cell lung cancer.
[J].2018,10(4).
[23]Qiu, Tianzhu,Zhou, Xin,Wang, Jian,etc.
MiR-145, miR-133a and miR-133b inhibit proliferation, migration, invasion and cell cycle progression via targeting transcription factor Sp1 in gastric cancer
[J].2014,588(7).
[24]K J, Livak,T D, Schmittgen.
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.
[J].2001,25.
[25].
MicroRNAs: Genomics, Biogenesis, Mechanism, and Function
[J].2004,116(2).
[26]Hanshao Liu,Lin Zhu,Bingya Liu,etc.
Genome-wide microRNA profiles identify miR-378 as a serum biomarker for early detection of gastric cancer
[J].2012,316(2).
[27]Heegaard,N.H.H.,Bowman,E.D.,Harris,C.C.,etc.
Circulating micro-RNA expression profiles in early stage nonsmall cell lung cancer
[J].2012,130(6).
[28]Qing, Geng,Tao, Fan,Boyou, Zhang,etc.
Five microRNAs in plasma as novel biomarkers for screening of early-stage non-small cell lung cancer.
[J].2014,15.
[29]Su,C.,Fan,L.,Zhou,C.,etc.
MiR-21 overexpression is associated with acquired resistance of EGFR-TKI in non-small cell lung cancer
[J].2014,83(2).
[30]Torre, Lindsey A.,Bray, Freddie,Siegel, Rebecca L.,etc.
Global Cancer Statistics, 2012
[J].2015,65(2).
[31]Yin, Zijun,Xu, Meng,Li, Ping.
miRNA-221 acts as an oncogenic role by directly targeting TIMP2 in non-small-cell lung carcinoma
[J].2017,620.
[32]Hai, Li,Xin, Zhou,Jun, Zhu,etc.
MiR-4728-3p could act as a marker of HER2 status.
[J].2015,15.
[33]Ying Zhu,Tao Li,Gang Chen,etc.
Identification of a serum microRNA expression signature for detection of lung cancer, involving miR-23b, miR-221, miR-148b and miR-423-3p
[J].2017,114.
[34]Romano,Di Leva G,Garofalo M.
miR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation.
[J].2009,16(6).
[35]Hong Jiang,Jijun Liu,Yingtao Chen,etc.
Up‐regulation of mir‐10b predicate advanced clinicopathological features and liver metastasis in colorectal cancer
[J].2016,5(10).
[36].
A six-microRNA panel in plasma was identified as a potential biomarker for lung adenocarcinoma diagnosis.
[J].2017,8(4).
[37]Jochen, Gaedcke,Marian, Grade,Jordi, Camps,etc.
The rectal cancer microRNAome--microRNA expression in rectal cancer and matched normal mucosa.
[J].2012,18(18).
[38].
Identification and validation of reference genes for qPCR detection of serum microRNAs in colorectal adenocarcinoma patients.
[J].2016.
[39]Mahdi, Mahdipour,Helena T A, van Tol,Tom A E, Stout,etc.
Validating reference microRNAs for normalizing qRT-PCR data in bovine oocytes and preimplantation embryos.
[J].2015,15.
[40]Xin, Zhou,Wei, Wen,Jun, Zhu,etc.
A six-microRNA signature in plasma was identified as a potential biomarker in diagnosis of esophageal squamous cell carcinoma.
[J].2017,8(21).
[41]Johannes M,Steuber T,Kuner R,etc.
Circulating miRNAs are correlated with tumor progression in prostate cancer.
[J].2011,128(3).
[42]Hornby,R.J.,Lewis,P.S.,Dear,J.,etc.
MicroRNAs as potential circulating biomarkers of drug-induced liver injury: Key current and future issues for translation to humans
[J].2014,7(3).
[43]Petriella, D.,De Summa, S.,Lacalamita, R.,etc.
miRNA profiling in serum and tissue samples to assess noninvasive biomarkers for NSCLC clinical outcome
[J].2016,37(4).
[44]Shiotani,A.,Murao,T.,Kimura,Y.,etc.
Identification of serum miRNAs as novel non-invasive biomarkers for detection of high risk for early gastric cancer
[J].2013,109(9).
[45]Zhang, J.,Xu, L.,Yang, Z.,etc.
MicroRNA-10b indicates a poor prognosis of non-small cell lung cancer and targets E-cadherin
[J].2015,17(3).
[46]Dong-Sheng, Zhao,Yan, Chen,Hui, Jiang,etc.
Serum miR-210 and miR-30a expressions tend to revert to fetal levels in Chinese adult patients with chronic heart failure.
[J].1900,22.
[47]Mirzaei, Hamed,Khataminfar, Sara,Mohammadparast, Saeid,etc.
Circulating microRNAs as Potential Diagnostic Biomarkers and Therapeutic Targets in Gastric Cancer: Current Status and Future Perspectives
[J].2016,23(36).
WanfangData CO.,Ltd All Rights Reserved
About WanfangData
|
Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:
yiyao@wanfangdata.com.cn